Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020


 

Clinical Trials of Immune Checkpoint Inhibitors in Early Stage Breast Cancer: Neoadjuvant Durvalumab, Neoadjuvant Pembrolizumab, Pembro 8-no AC, Chemo + Pembro, & Atezolizumab with Neoadjuvant Chemo

877 views
February 27, 2020
0 Comments
Login to view comments. Click here to Login
Breast Cancer Updates